在不使用蛋白酶抑制剂的情况下研究非酒精性脂肪性肝病（NAFLD）中的血液胃饥饿素和肥胖抑制素是否合适？ - Suppr | 超能文献

Is it appropriate to study blood ghrelin and obestatin in non-alcoholic fatty liver disease (NAFLD) without using protease inhibitors?

作者信息

Aydin Suleyman

出版信息

Ann Hepatol. 2012 Jan-Feb;11(1):145-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Is it appropriate to study blood ghrelin and obestatin in non-alcoholic fatty liver disease (NAFLD) without using protease inhibitors?在不使用蛋白酶抑制剂的情况下研究非酒精性脂肪性肝病（NAFLD）中的血液胃饥饿素和肥胖抑制素是否合适？

Ann Hepatol. 2012 Jan-Feb;11(1):145-6.

2

High ghrelin and obestatin levels and low risk of developing fatty liver.高胃饥饿素和肥胖抑制素水平与低脂肪肝发病风险相关。

Ann Hepatol. 2010 Jan-Mar;9(1):52-7.

3

Association of obestatin, ghrelin, and inflammatory cytokines in obese patients with non-alcoholic fatty liver disease.肥胖症患者非酒精性脂肪性肝病中肥胖素、ghrelin 和炎性细胞因子的相关性。

Obes Surg. 2011 Nov;21(11):1750-7. doi: 10.1007/s11695-011-0475-1.

4

To what extent is it right to measure serum vaspin, obestatin, and apelin-36 levels without a protease inhibitor in nonalcoholic fatty liver disease?在非酒精性脂肪性肝病中，在不使用蛋白酶抑制剂的情况下检测血清内脂素、肥胖抑制素和apelin-36水平，这种做法在多大程度上是正确的？

Metabolism. 2011 Jul;60(7):e1; author reply e2. doi: 10.1016/j.metabol.2011.01.015. Epub 2011 Mar 11.

5

Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation.脑肠肽 Obestatin 通过抑制摄食、增强肝脂联素信号和阻止胃饥饿素酰化来保护并逆转大鼠非酒精性脂肪性肝病及其相关的胰岛素抵抗。

Arch Physiol Biochem. 2019 Feb;125(1):64-78. doi: 10.1080/13813455.2018.1437638. Epub 2018 Feb 10.

6

Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者血清中 vaspin、obestatin 和 apelin-36 的水平。

Metabolism. 2011 Apr;60(4):544-9. doi: 10.1016/j.metabol.2010.05.008. Epub 2010 Jun 26.

7

How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.脂联素、瘦素和胃饥饿素如何协同作用并与非酒精性脂肪性肝病的严重程度相关。

Eur J Gastroenterol Hepatol. 2012 Oct;24(10):1166-72. doi: 10.1097/MEG.0b013e32835609b0.

8

Independent factors associated with altered plasma active ghrelin levels in HCV-infected patients.与 HCV 感染患者血浆活性 ghrelin 水平改变相关的独立因素。

Liver Int. 2013 Nov;33(10):1510-6. doi: 10.1111/liv.12235. Epub 2013 Jun 28.

9

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.系统评价：成人非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学和自然史。

Aliment Pharmacol Ther. 2011 Aug;34(3):274-85. doi: 10.1111/j.1365-2036.2011.04724.x. Epub 2011 May 30.

10

Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors?苏丹人群中的非酒精性脂肪性肝病（NAFLD）：患病率及危险因素是什么？

Arab J Gastroenterol. 2014 Mar;15(1):12-5. doi: 10.1016/j.ajg.2014.01.008. Epub 2014 Feb 12.

引用本文的文献

1

Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients.2型糖尿病患者中酰基胃泌素的诊断准确性及其与非酒精性脂肪性肝病的关联

J Diabetes Metab Disord. 2015 May 19;14:44. doi: 10.1186/s40200-015-0170-1. eCollection 2015.

2

Ghrelin: a new treatment for non-alcoholic fatty liver disease?胃饥饿素：非酒精性脂肪性肝病的一种新疗法？

Endocrine. 2013 Apr;43(2):247-8. doi: 10.1007/s12020-012-9800-2. Epub 2012 Sep 20.